Latest filing published 01 May 2024 for Petmed Express INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -21.4%Entry US$7.29 · Close at T+365 US$5.73
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mathew N. Hulett: trading record in brief
Mathew N. Hulett has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Rosetta Stone Inc and Petmed Express Inc. Between 21 August 2017 and 29 April 2024, the trades on record add up to 25 filings.
In open-market terms, that means 1 purchase worth €95k on one side and 3 sales worth €60k on the other. The net balance comes to €34k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 18 share grants.
The record was last updated on 1 May 2024 with a transaction in Petmed Express Inc. The clock since the last published purchase (7 November 2023) now reads 1,097 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mathew N. Hulett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 510,000 shares0Common StockSEC:0001040130-24-000026:0
- 13,850 shares@ US$7.26100.0% of flowCommon StockSEC:0001040130-23-000084:0Canonical exit: 1 Feb 2024 (T+90)
- 78,254 shares@ US$30.0055.3% of flowCommon StockSEC:0001209191-20-055080:0
- 35,802 shares@ US$30.0025.3% of flowCommon StockSEC:0001209191-20-055080:1
- 766 shares@ US$29.250.5% of flowCommon StockSEC:0001209191-20-048390:0
- 1,225 shares@ US$17.930.6% of flowCommon StockSEC:0001209191-20-013401:0
- 87 shares@ US$18.830.0% of flowCommon StockSEC:0001209191-20-012815:0
- 538 shares@ US$18.830.3% of flowCommon StockSEC:0001209191-20-012815:1
- 7,660 shares@ US$19.583.8% of flowCommon StockSEC:0001209191-20-012303:0
- 25,536 shares@ US$19.5812.6% of flowCommon StockSEC:0001209191-20-012303:1
- 1,940 shares@ US$18.910.9% of flowCommon StockSEC:0001209191-20-012303:2
- 1,138 shares@ US$18.290.5% of flowCommon StockSEC:0001209191-20-002499:0
- 1,101 shares@ US$20.000.5% of flowCommon StockSEC:0001209191-19-055248:0
- 741 shares@ US$18.270.3% of flowCommon StockSEC:0001209191-19-047495:0
- 1,010 shares@ US$22.560.5% of flowCommon StockSEC:0001209191-19-037672:0
- 1,000 shares@ US$22.980.5% of flowCommon StockSEC:0001209191-19-019439:0
- 427 shares@ US$15.320.2% of flowCommon StockSEC:0001209191-19-014156:0
- 1,439 shares@ US$15.290.5% of flowCommon StockSEC:0001209191-19-014156:1
- 1,737 shares0Common StockSEC:0001209191-19-013104:0
- 347 shares0Common StockSEC:0001209191-19-013104:1
- 8,686 shares0Common StockSEC:0001209191-19-013104:2
- 15,043 shares0Common StockSEC:0001209191-19-001961:0
- 769 shares@ US$15.700.3% of flowCommon StockSEC:0001351285-18-000093:0
- 18,926 shares0Common StockSEC:0001123292-18-000395:0
- 12,500 shares0Common StockSEC:0001351285-17-000092:0
25 of 25 declarations
